Metabolic effects of cyclic 9- -D-arabinofuranosyladenine 3',5'-monophosphate in L1210 cells.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001089:Arabinose / Q000378:metabolism / Q000494:pharmacology*; D002478:Cells, Cultured; D003470:Culture Media; D000242:Cyclic AMP / Q000378:metabolism / Q000494:pharmacology*; D004254:DNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D004273:DNA, Neoplasm / Q000096:biosynthesis; D006868:Hydrolysis; D007288:Inosine / Q000494:pharmacology; D007939:Leukemia L1210 / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D010727:Phosphoric Diester Hydrolases / Q000494:pharmacology; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013440:Sulfides / Q000494:pharmacology; D013806:Theophylline / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium; D014529:Uridine / Q000378:metabolism
D003470:Culture Media; D004273:DNA, Neoplasm; D012334:RNA, Neoplasm; D013440:Sulfides; D014316:Tritium; D007288:Inosine; D000255:Adenosine Triphosphate; D001089:Arabinose; D013806:Theophylline; D000242:Cyclic AMP; D004254:DNA Nucleotidyltransferases; D010727:Phosphoric Diester Hydrolases; D013936:Thymidine; D014529:Uridine